Skip to content

Effect of heparin reversal by protamine sulfate on the outcome of thrombolysis in acute ischemic stroke after percutaneous coronary intervention

Effect of heparin reversal by protamine sulfate on the outcome of thrombolysis in acute ischemic stroke after percutaneous coronary intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202109714591017
Enrollment
44
Registered
2021-09-28
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

IV alteplase
loading antiplatelets

Sponsors

neurology department ain shams university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults (~18 years or over) undergoing elective or emergency PCI. 2. Acute ischemic stroke, defined as focal neurological deficit occurring during or immediately after PCI, and diagnosed by an expert neurologist. 3. Stroke within 4 hours of onset. 4. National institutes of health stroke scale (NIHSS) ranging from 4-15. 5. NIHSS < 4 if causing significant deficit (e.g.: aphasia). 6. CT brain is negative for hemorrhage. 7. Patients fulfilled the inclusion criteria for TPA. 8. All participants or their relatives give written consent for participation in this study.

Exclusion criteria

Exclusion criteria: 1- Adolescents or children (15). 4- Mild neurological deficit (NIH <3) and no strategic deficit. 5- Stroke onset beyond 4.5 hours 6- Exclusion criteria for TPA

Design outcomes

Primary

MeasureTime frame
Change in NIHSS score from baseline to 24hrs and on discharge . ; Rate of significant bleeding events and the rate of mortality during the hospital stay ; Change in NIHSS score from baseline to 24hrs and on discharge . ; Rate of significant bleeding events and the rate of mortality during the hospital stay

Secondary

MeasureTime frame
secondary outcome measures were mRS on discharge and after 3months ;duration of hospital stay

Countries

Egypt

Contacts

Public Contactahmed elbasiouny

professor

e_sara2016@yahoo.com+201222132125

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026